As of Wednesday close, DENTSPLY SIRONA Inc.’s (NASDAQ:XRAY) stock was down -$0.25, moving down -0.67 percent to $37.34. The average number of shares traded per day over the past five days has been 1,260,600 shares. 1 time new highs have been achieved over the past 5 days, with a -$1.13 fall in that time frame. In the last twenty days, the average volume was 1,436,255, while in the previous 50 days, it was 1,541,808.
Since last month, XRAY stock retreated -7.92%. Shares of the company fell to $37.21 on 08/16/23, the lowest level in the past month. A 52-week high of $43.24 was reached on 05/03/23 after having rallying from a 52-week low of $26.48. Since the beginning of this year, XRAY’s stock price has risen by 17.27% or $5.50, and marked a new high 18 times. However, the stock has declined by -13.64% since its 52-week high.
XRAY stock investors should be aware that DENTSPLY SIRONA Inc. (XRAY) stock had its last reported insider trading activity 107 days ago on May 02. BRANDT ERIC, the Director of the company, disposed of 6,200 shares for $42.17 on May 02. It resulted in a $261,454 divestment by the insider. Staehler Cord Friedrich sold 4,000 shares at an average price of $39.33 on Mar 07. The insider now owns 97,693 shares following the transaction. On Nov 15, Director LUCIER GREGORY T bought 6,000 shares at $31.45 apiece. The transaction was valued at $188,700.
Valuation Metrics
The stock’s beta is 0.98. Besides these, the trailing price-to-sales (P/S) ratio of 1.99, the price-to-book (PB) ratio of 2.13, and the price-to-cash flow ratio of 39.64 may also be considered.
The latest dividend of $0.14 per share was paid out, remained unchanged from last year’s $0.14.
Financial Health
In the three months ended June 29, DENTSPLY SIRONA Inc.’s quick ratio stood at 1.00, while its current ratio was 1.50, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.50, and the total debt-to-equity ratio was 0.57. On the profitability front, the trailing twelve-month gross margin is 53.30% percent. In the year ended June 29, EBITDA margin amounted to 17.72%, whereas operating margins totaled -27.40%. Based on annual data, XRAY earned $2.13 billion in gross profit and brought in $3.92 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -14.50%. Return on equity (ROE) for the past 12 months was -27.80%.
In DENTSPLY SIRONA Inc.’s quarter-end financial report for June 29, it reported total debt of $1.84 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. XRAY’s revenue rose 0.49% to $978.0 million during the quarter, while net income inched up to $1.03 billion. While analysts expected DENTSPLY SIRONA Inc. to report $0.43 quarterly earnings, the actual figure was $0.51 per share, beating the consensus estimate by 18.60%. During the quarter, the company generated $166.0 million in EBITDA. The liabilities of DENTSPLY SIRONA Inc. were 3.95 billion at the end of its most recent quarter ended June 29, and its total debt was $2.28 billion. The value of shareholders’ equity is $211.72 million.
Technical Picture
This quick technical analysis looks at DENTSPLY SIRONA Inc.’s (XRAY) price momentum. With a historical volatility rate of 15.31%, the RSI 9-day stood at 22.45% on 16 August.
With respect to its five-day moving average, the current DENTSPLY SIRONA Inc. price is down by -2.94% percent or -$1.13. At present, XRAY shares trade -8.19% below its 20-day simple moving average and +1.58% percent above its 100-day simple moving average. However, the stock is currently trading approximately -4.06% below its SMA50 and +22.39% above its SMA200.
Stochastic coefficient K was 3.37% and Stochastic coefficient D was 8.88%, while ATR was 0.78. Given the Stochastic reading of 2.99% for the 14-day period, the RSI (14) reading has been calculated as 30.27%. As of today, the MACD Oscillator reading stands at -0.84, while the 14-day reading stands at -1.63.
Analyst Ratings
William Blair upgraded its rating on DENTSPLY SIRONA Inc. (NASDAQ: XRAY) to a Mkt perform in a note to investors on January 12, 2023. The analysts firm previously had an Underperform rating on the stock.DENTSPLY SIRONA Inc. (XRAY) has been rated Overweight by analysts. According to 0 brokerage firms, XRAY is a sell, and 8 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate DENTSPLY SIRONA Inc. stock as buy, with 4 recommending it as overweight.
With a median target price of $44.00, the current consensus forecast for the stock is $40.00 – $51.00. Based on these forecasts, analysts predict DENTSPLY SIRONA Inc. (XRAY) will achieve an average price target of $44.30.
